Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Cerimon Pharmaceuticals
Cerimon Pharmaceuticals develops and sells therapeutics for autoimmune diseases and inflammation.
Sector
Subsector
Keywords
Location
total rounds
total raised
Corbus Pharmaceuticals
Corbus Pharmaceuticals Holdings, Inc. is developing and commercializing novel therapeutics for inflammatory and fibrotic diseases.
Sector
Subsector
Location
total rounds
total raised
Omeros
Omeros develops therapeutics for inflammation, coagulopathies, and CNS disorders.
Sector
Subsector
Keywords
Location
total rounds
total raised
Anthera Pharmaceuticals
Anthera Pharmaceuticals develops and sells treatments for inflammation-related diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
M&A Details1
Financials
Funding Rounds9
Number of Funding Rounds
Money Raised
Their latest funding was raised on 06.04.2016. Their latest round Post-IPO Debt
Hercules Capital
Hercules Capital, Inc. provides senior secured venture growth loans to high-growth, innovative venture capital-backed companies.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
U.S. Department of the Treasury
The Department of the Treasury manages the money resources of the United States.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors8
Number of lead investors
Number of investors
Schering AG
Bayer is a global enterprise that specializes in healthcare, nutrition, and high-tech materials.
Sector
Subsector
Location
count Of Investments
count Of Exists
Care Capital
Care Capital invests in entrepreneurial companies developing pharmaceutical assets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Venrock
Venrock partners with entrepreneurs to build disruptive, successful companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Anders Hove
Anders Hove is the Partner and Founder at acorn Bioventures. Attended INSEAD.
current job
People
Founders2
Lucy Shapiro
Lucy Shapiro, Ph.D., one of our co-founders, has served as a member of our board since our inception in 2000. She is also the co-chair of our scientific advisory board. Dr. Shapiro, the Virginia and D.K. Ludwig Professor of Cancer Research and Director of the Beckman Center in the School of Medicine at Stanford University, has been at Stanford University since 1989. Dr. Shapiro is a Fellow of the American Association for the Advancement of Sciences and has been elected to the National Academy of Sciences, the American Academy of Microbiology, the American Academy of Arts and Sciences and the Institute of Medicine of the National Academy of Sciences for her work in the fields of molecular biology and microbiology. She was elected to the American Philosophical Society and received the Selman Waksman Award from the National Academy of Sciences in 2005. She was a non-executive director of GlaxoSmithKline from 2001 to 2006 and is on the board of Gen-Probe, Incorporated. She received a B.S. from Brooklyn College and a Ph.D. in molecular biology from the Albert Einstein School of Medicine.
current job
organization founded
Lucy Shapiro
Stephen Benkovic
Stephen J. Benkovic, also known as Steve, Ph.D., was a Scientific Advisor at Ascent Biomedical Ventures and Azevan Pharmaceuticals, Inc. until January 27th 2016. Stephen Benkovic is a Scientific Partner, Rho Ventures at Rho Capital Partners, Inc. Stephen Benkovic began working with the firm in the mid-1990s prior to joining as a Scientific Partner in 2001. He also serves as a Special Limited Partner at Care Capital. Stephen Benkovic is a Co-Founder and Director at Anacor Pharmaceuticals Inc. He is a Director of Boragen Inc. His current and recent Scientific Advisory Board seats include Senomyx, Solexa, Dihedron, Archemix, and Cumbre. He serves as a Member of Scientific Advisory Board of Odyssey Thera, Inc. He is the Member of Scientific Advisory Board of Adnexus Therapeutics, Inc. Stephen Benkovic serves as a Member of Science Advisory Board at Myriant Technologies LLC. Stephen Benkovic is the Evan Pugh Professor of Chemistry and Eberly Chair of Chemistry at Penn State University. After a period as a Postdoctoral Research Associate at the University of California, Santa Barbara, he joined the Chemistry Department at Penn State University in 1965 and became a full Professor of Chemistry in 1970, followed by recognitions as an Evan Pugh Professor of Chemistry, and in 1988, the holder of the Eberly Chair in Chemistry. Stephen Benkovic's work has been recognized by awards and fellowships including: Alfred P. Sloan Fellowship, NIH Career Development Award, Guggenheim Fellowship, the Pfizer Award in Enzyme Chemistry, the Gowland Hopkin Award, the Repligen Award for Chemistry of Biological Processes, the Alfred Bader Award, the Chemical Pioneer Award from the American Institute of Chemists, and the Christian B. Afinsen Award. His research has emphasized the study of the mechanisms of enzyme-catalyzed reactions. He formerly headed the Scientific Advisory Board of GlaxoSmithKline. Stephen Benkovic recent work has focused on the mechanism of action of the folate requiring transformylase enzymes in de novo purine biosynthesis, the characteristics of enzymes in antibiotic resistance, the assembly and kinetic characteristics of the T4 replication complex; the importance of dynamic coupling of proximal and distal residues on the function of dihydrofolate reductase, and the development of novel catalysts based on biological materials. Stephen Benkovic earned a Ph.D. in Organic Chemistry from the Cornell University. He received a B.S. in Chemistry and an A.B. in English literature from the Lehigh University.
current job
Stephen Benkovic
Employee Profiles41
Ryan T Sullivan
Executive Vice President & General Counsel
Carmen R Rodriguez
Senior Vice President of Regulatory Affairs & Quality
James R. Marconi
Vice President of Finance & Controller
Yasheen Zhou
Head of computational chemistry group, senior research fellow
Jacob J. Plattner
Senior Vice President of Research